Predictive and prognostic potential of pretreatment 68Ga-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Assadi, Majid
Manafi-Farid, Reyhaneh
Jafai, Esmail
Keshavarz, Ahmad
Divband, GhasemAli
Moradi, Mohammad Mobin
Adinehpour, Zohreh
Samimi, Rezvan
Dadgar, Habibollah
Mayer, Benjamin
Prasad, Vikas
机构：
[1] Bushehr Univ Med Sci, Bushehr, Iran
[2] Univ Tehran Med Sci, Tehran, Iran
[3] Persian Gulf Univ, Bushehr, Iran
[4] Khatam PET CT Ctr, Tehran, Iran
[5] Shahid Beheshti Univ, Tehran, Iran
[6] Razavi Hosp, Canc Res Ctr, Mashhad, Iran
[7] Univ Ulm, Ulm, Germany
[8] Univ Hosp Ulm, Ulm, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
200
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Heterogeneity of [68Ga]Ga-PSMA-11 PET/CT in metastatic castration-resistant prostate cancer: genomic characteristics and association with abiraterone response
    Jian Pan
    Jinou Zhao
    Xudong Ni
    Bin Zhu
    Xiaoxin Hu
    Qifeng Wang
    Yu Wei
    Tingwei Zhang
    Hualei Gan
    Beihe Wang
    Junlong Wu
    Shaoli Song
    Chang Liu
    Dingwei Ye
    Yao Zhu
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1822 - 1832
  • [22] Heterogeneity of [68Ga]Ga-PSMA-11 PET/CT in metastatic castration-resistant prostate cancer: genomic characteristics and association with abiraterone response
    Pan, Jian
    Zhao, Jinou
    Ni, Xudong
    Zhu, Bin
    Hu, Xiaoxin
    Wang, Qifeng
    Wei, Yu
    Zhang, Tingwei
    Gan, Hualei
    Wang, Beihe
    Wu, Junlong
    Song, Shaoli
    Liu, Chang
    Ye, Dingwei
    Zhu, Yao
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (06) : 1822 - 1832
  • [23] Treatment response evaluation with PSMA-PET/CT imaging in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Kleiburg, F.
    De Geus-Oei, L. F.
    Luelmo, S. A. C.
    Spijkerman, R.
    Toonen, F. A. J.
    Smit, F.
    Van der Hulle, T.
    Heijmen, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S540 - S540
  • [24] 68Ga-PSMA PET/CT Revealing Unusual Inguinal Canal and Distant Nodal Metastasis in a Case of Castration-Resistant Prostate Cancer
    Vadi, Shelvin Kumar
    Kumar, Rajender
    Mittal, Bhagwant Rai
    Singh, Harmandeep
    Singh, Shrawan Kumar
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (04) : 279 - 281
  • [25] 68Ga-FAPI-46 PET/CT in a Metastatic Castration-Resistant Prostate Cancer Patient With Low PSMA Expression
    Aryana, Kamran
    Manafi-Farid, Reyhaneh
    Amini, Hamidreza
    Divband, Ghasemali
    Moghadam, Soroush Zarehparvar
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (11) : 972 - 973
  • [26] Fibroblast Activation Protein-Targeted PET Imaging of Metastatic Castration-Resistant Prostate Cancer Compared With 68Ga-PSMA and 18F-FDG PET/CT
    Isik, Emine Goknur
    Has-Simsek, Duygu
    Sanli, Oner
    Sanli, Yasemin
    Kuyumcu, Serkan
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (01) : E54 - E55
  • [27] FAPI, PSMA and FDG PET/CT in patients with advanced metastatic castration-resistant prostate cancer (mCRPC): a triple tracer comparison
    Pabst, K. M.
    Fendler, W. P.
    Hadaschik, B.
    Kesch, C.
    Hirmas, N.
    Kessler, L.
    Gruenwald, V.
    Hamacher, R.
    Nader, M.
    Berliner, C.
    Umutlu, L.
    Puellen, L.
    Herrmann, K.
    Lueckerath, K.
    Castellucci, P.
    Fanti, S.
    Mei, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S118 - S119
  • [28] Response assessment using [68Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancer
    Grubmueller, Bernhard
    Rasul, Sazan
    Baltzer, Pascal
    Fajkovic, Harun
    D'Andrea, David
    Berndl, Florian
    Maj-Hes, Agnes
    Grubmueller, Karl Hermann
    Mitterhauser, Markus
    Wadsak, Wolfgang
    Pfaff, Sarah
    Shariat, Shahrokh F.
    Hacker, Marcus
    Kramer, Gero
    Hartenbach, Markus
    PROSTATE, 2020, 80 (01): : 74 - 82
  • [29] Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer
    Yamada, Yasutaka
    Sakamoto, Shinichi
    Rii, Junryo
    Yamamoto, Satoshi
    Kamada, Shuhei
    Imamura, Yusuke
    Nakamura, Kazuyoshi
    Komiya, Akira
    Nakatsu, Hiroomi
    Ichikawa, Tomohiko
    PROSTATE, 2020, 80 (07): : 559 - 569
  • [30] Cabazitaxel for octogenarian patients with metastatic castration-resistant prostate cancer (MCRPC)
    Tralongo, P.
    Bordonaro, S.
    Di Lorenzo, G.
    Borsellino, N.
    Facchini, G.
    Rossetti, S.
    Martelli, V.
    Longo, V.
    Tralongo, A. C.
    Caspani, F.
    Tuzi, A.
    Spada, M.
    Calvani, N.
    Carlini, P.
    De Giorgi, U. F. F.
    ANNALS OF ONCOLOGY, 2019, 30
12345